β Scribed by C Pestoni; C Paredes-Suarez; C Peteiro; J Toribio
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background The aim of the present analysis was to retrospectively evaluate outcomes in patients with cutaneous angiosarcoma of the face/scalp treated curatively with surgery, radiation therapy (RT), or a combination of surgery and RT. ## Methods In all, 70 patients with nonmetasta
## ABSTRACT Cutaneous angiosarcoma is a rare tumour of vascular origin, which has a poor prognosis because of its high potential for metastasis. We report the case of a 57βyearβold man with an 8βmonth history of a progressively enlarging, asymptomatic red patch over the left periorbital region of t
## BACKGROUND. Angiosarcomas are rare tumors. Based on a complete response observed in a patient with angiosarcoma of the scalp treated with paclitaxel in a Phase II trial, the authors treated a cohort of patients with angiosarcoma of the scalp or face with paclitaxel as single agent. ## METHODS.